Fatty Liver Symposium 2022-Join us to get the latest updates and information on treatment options for fatty liver disease.
8:30am – 8:40am Welcome-Dina Halegoua-DeMarzio, MD & Maria Lagarde, MD
8:40am – 9:00am What is Non-Alcoholic Fatty Liver Disease (NAFLD)? Dina Halegoua-DeMarzio, MD
9:00am – 9:20am Evaluation of Non-Alcoholic Fatty Liver Disease – Maria Lagarde, MD
9:20am -9:40am Lifestyle Modification in Non-Alcoholic Fatty Liver Disease – Emily Rubin, RD, LDN
9:40am -10:00am Diabetes and the Liver- Monika Shirodkar, MD
10:00 – 10:15 “Movement Break”
10:15am -10:35am Role of Bariatric Surgery in the Treatment of Non-Alcoholic SteatoHepatitis (NASH) – Talar Talarian, MD
10:35am – 10:55am Cardiovascular Risk in NASH/NAFLD – Sahil Banka, MD
10:55am – 11:15am Clinical Trials for new NASH treatments- Dina Halegoua-DeMarzio, MD & Maria Lagarde, MD
11:15am – 11:35am Alcohol Safety and Addiction Counseling- Ryan Healy, MS, LPC
11:35am – 12:00pm Question & Answer Session – Panel Discussion with all Speakers
This program is jointly sponsored by Thomas Jefferson University Hospital & Einstein Healthcare Network-now a part of Jefferson Health in collaboration with the Liver Community Alliance & American Liver Foundation.
Questions? Please contact Rachel Komitzky 267-355-4251